Anne Daub

Anne Daub

Partner, Therapeutics atDeerfieldNew York

Anne Daub is a Partner on the Therapeutics team at Deerfield, joining in 2024. She previously held analyst and vice president roles at several investment firms and holds a graduate degree in Finance.

What Anne can write

Writes checks ofNot reported
Comes in atSeedLead preference not reported
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Career

  1. Visium Asset Management · Analyst
  2. Soros Fund Management LLC · Senior Analyst
  3. Citadel LLC · Senior Analyst
  4. T. Rowe Price · Vice President and Biotechnology Senior Analyst
  5. Deerfield · Partner
    Now
  6. J.P. Morgan Securities Inc.
  7. Integrated Finance Ltd.
  8. Bear Stearns & Co.

Focus

therapeuticsbiotechnology

Education

H.E.C Graduate School of Management, graduate degree in Finance

Also at Deerfield

Partners like Anne

At firms with a similar stage, sector and check size.

Alert me when Deerfield is active

One email when Anne's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Anne Daub?

Anne Daub is a Partner on the Therapeutics team at Deerfield, joining in 2024. She previously held analyst and vice president roles at several investment firms and holds a graduate degree in Finance.

How much does Anne Daub invest?

Deerfield has not reported a check size. It invests at seed.

How do I pitch Anne Daub?

A warm intro from a founder Deerfield backed works best.

What did Anne Daub do before Deerfield?

Analyst at Visium Asset Management; Senior Analyst at Soros Fund Management LLC; Senior Analyst at Citadel LLC; Vice President and Biotechnology Senior Analyst at T. Rowe Price; J.P. Morgan Securities Inc.; Integrated Finance Ltd.; Bear Stearns & Co..

Last updated 2026-10-15. Is this you? Ask for a correction.